Regulatory approval, CE marking & more — 3 GI company key notes

Here are three updates on GI companies from the past week:

Advertisement

Pentax Medical obtained a CE Mark for its DEC Duodenoscope.

VolitionRx is planning a European launch of its CRC screening product in 2018.

Immuron is making progress on its three clinical trials for IMM-124E, a nonalcoholic steatohepatitis and nonalcoholic fatty liver disease treatment.

More articles on gastroenterology: 
GI leader to know: Dr. Francis Farraye of Boston Medical Center
Stock market week-in-review for 5 large GI companies — Sept. 11-15
Patient engagement, case conference less effective in IBD care than perceived

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

  • Birmingham (Ala.) Gastroenterology has opened a clinic in Jasper, Ala., expanding access to digestive health services in the region, the…

  • Premier Health Partners has acquired Dayton, Ohio-based Digestive Specialists, according to a notice posted on the website of law firm…

Advertisement

Comments are closed.